Directed discovery of high-loading nanoaggregates enabled by drug-matched oligo-peptide excipients
Year: 2025
Type: article
Source: Chem
Institutions: The Graduate Center, CUNY, Memorial Sloan Kettering Cancer Center, City University of New York, Hunter College, CUNY Advanced Science Research Center, Tri-Institutional PhD Program in Chemical Biology, City College of New York, Brooklyn College, Cornell University, Weill Cornell Medicine
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
Funders: National Science Foundation, American Cancer Society, City University of New York, Tow Foundation, Pershing Square Sohn Cancer Research Alliance, Commonwealth Foundation for Cancer Research Foundation, Expect Miracles Foundation, National Institutes of Health, Office of Naval Research, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, Air Force Office of Scientific Research
Awards: G1705409867, Tumor-Selective Delivery Approaches for Medulloblastoma, G2377374449, G372934033, Nanotechnology as a therapeutic approach in arteriovenous fistula maturation, G3922212835, CAREER: A Quantitative Nanosensor to Measure Redox Potential in Living Systems, P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment, G6812410181, G7010986926, Renal tubule-specific nanotherapeutics for acute kidney injury, Cancer Center Support Grant, Inducing Neural Maturation in Medulloblastoma by Targeting EZH2
OpenAlex ID: W4406798110